VAL-083 IN COMBINATION WITH AZD1775 FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA

被引：0
|
作者：
Subramaniam, Bavani [1 ]
Roy, Debasish [1 ]
Woldegerima, Ayda [1 ]
Przystal, Justyna [2 ]
Zhang, Jie [3 ]
Laternser, Sandra [2 ]
Kritzer, Bettina [2 ]
Yadavilli, Sridevi [1 ]
Mueller, Sabine [2 ,3 ]
Packer, Roger [1 ,4 ]
Nazarian, Javad [1 ,2 ]
机构：
[1] Childrens Natl Hosp, Ctr Genet Med Res, Washington, DC USA
[2] Univ Childrens Hosp Zurich, Childrens Res Ctr, Dept Oncol, Zurich, Switzerland
[3] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA
[4] Childrens Natl Hosp, Gilbert Family Neurofibromatosis Inst, Washington, DC USA
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae064.091
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DIPG-38
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers
    Gonzalez-Ochoa, Eduardo
    Milosevic, Michael
    Corr, Bradley
    Abbruzzese, James L.
    Girda, Eugenia
    Miller, Rachel W.
    Croke, Jennifer
    Mackay, Helen
    Lee, Yeh Chen
    Bowering, Valerie
    Ramsahai, Janelle
    Wang, Lisa
    D'Souza, April
    Kunos, Charles A.
    Oza, Amit M.
    Lheureux, Stephanie
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (08) : 1208 - 1214
  • [42] IDENTIFICATION AND TARGETING OF METABOLIC VULNERABILITIES IN COMBINATION WITH PDGFRA-INHIBITION IN DIFFUSE MIDLINE GLIOMA
    Neyazi, Sina
    Gowda, Pruthvi S.
    Trissal, Maria
    Fonticella, Jay-Miguel
    Portero, Erika P.
    Haley-Read, John-Paul
    Anderson, Emily P.
    Danial, Nika N.
    Filbin, Mariella G.
    NEURO-ONCOLOGY, 2023, 25
  • [43] Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer
    Cuneo, Kyle C.
    Morgan, Meredith A.
    Sahai, Vaibhav
    Schipper, Matthew J.
    Parsels, Leslie A.
    Parsels, Joshua D.
    Devasia, Theresa
    Al-Hawaray, Mahmoud
    Cho, Clifford S.
    Nathan, Hari
    Maybaum, Jonathan
    Zalupski, Mark M.
    Lawrence, Theodore S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (29) : 2643 - +
  • [44] ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
    Jackson, Evangeline R.
    Duchatel, Ryan J.
    Staudt, Dilana E.
    Persson, Mika L.
    Mannan, Abdul
    Yadavilli, Sridevi
    Parackal, Sarah
    Game, Shaye
    Chong, Wai Chin
    Jayasekara, W. Samantha N.
    Le Grand, Marion
    Kearney, Padraic S.
    Douglas, Alicia M.
    Findlay, Izac J.
    Germon, Zacary P.
    McEwen, Holly P.
    Beitaki, Tyrone S.
    Patabendige, Adjanie
    Skerrett-Byrne, David A.
    Nixon, Brett
    Smith, Nathan D.
    Day, Bryan
    Manoharan, Neevika
    Nagabushan, Sumanth
    Hansford, Jordan R.
    Govender, Dinisha
    McCowage, Geoff B.
    Firestein, Ron
    Howlett, Meegan
    Endersby, Raelene
    Gottardo, Nicholas G.
    Alvaro, Frank
    Waszak, Sebastian M.
    Larsen, Martin R.
    Colino-Sanguino, Yolanda
    Valdes-Mora, Fatima
    Rakotomalala, Andria
    Meignan, Samuel
    Pasquier, Eddy
    Andre, Nicolas
    Hulleman, Esther
    Eisenstat, David D.
    Vitanza, Nicholas A.
    Nazarian, Javad
    Koschmann, Carl
    Mueller, Sabine
    Cain, Jason E.
    Dun, Matthew D.
    CANCER RESEARCH, 2023, 83 (14) : 2421 - 2437
  • [45] VAL-083 IS A NOVEL N7 ALKYLATING AGENT THAT INHIBITS THE GROWTH OF GLIOMA STEM AND NON-STEM CULTURES, INCLUDING TEMOZOLOMIDE-RESISTANT LINES
    Fouse, Shaun
    Steino, Anne
    Butowski, Nicholas
    Bacha, Jeffrey
    Brown, Dennis
    Costello, Joseph
    NEURO-ONCOLOGY, 2014, 16
  • [46] Phase II trial of AZD1775 in combination with carboplatin and paclitaxel in stage IV squamous cell lung cancer (sqNSCLC): Preliminary results.
    Gray, Jhanelle Elaine
    Tanvetyanon, Tawee
    Creelan, Ben C.
    Antonia, Scott Joseph
    Haura, Eric B.
    Williams, Charles C.
    Yaseen, Raheel
    Schell, Michael J.
    Godin, Robert
    Rix, Uwe
    Monteiro, Alvaro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma
    Mendez, Eduardo
    Rodriguez, Cristina P.
    Kao, Michael C.
    Raju, Sharat
    Diab, Ahmed
    Harbison, R. Alex
    Konnick, Eric Q.
    Mugundu, Ganesh M.
    Santana-Davila, Rafael
    Martins, Renato
    Futran, Neal D.
    Chow, Laura Q. M.
    CLINICAL CANCER RESEARCH, 2018, 24 (12) : 2740 - 2748
  • [48] Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma
    Sasaki, Takahiro
    Watanabe, Jun
    He, Xingyao
    Katagi, Hiroaki
    Suri, Amreena
    Ishi, Yukitomo
    Abe, Kouki
    Natsumeda, Manabu
    Frey II, William H.
    Zhang, Peng
    Hashizume, Rintaro
    JOURNAL OF NEUROSURGERY, 2023, 138 (06) : 1570 - 1579
  • [49] ADVANCING PRECISION TREATMENT FOR DIFFUSE MIDLINE GLIOMA: THE DMG LEARNING HUB INITIATIVE
    Lyons, Nicole
    Mehta, Misha
    Ward, Lisa
    NEURO-ONCOLOGY, 2024, 26
  • [50] ACETYLATION SUPPRESSION MEETS ONCOLYTIC VIRUSES FOR THE TREATMENT OF PEDIATRIC DIFFUSE MIDLINE GLIOMA
    Parthasarathy, Akhila
    Moure, Marc Garcia
    He, Jiasen
    Gillard, Andrew
    Paparella, Alyssa
    Shin, Dong Ho
    Lopez-Rivas, Andres
    Jiang, Hong
    Fan, Xuejun
    Hampton, Lethan
    Phoenix, Timothy
    Lang, Frederick
    Young, Nicolas
    Alonso, Marta
    Gomez-Manzano, Candelaria
    Fueyo, Juan
    NEURO-ONCOLOGY, 2024, 26
12345